Search results
Syndax reports encouraging results from AML treatment trials By Investing.com
Investing.com· 4 days agoSyndax Pharmaceuticals (NASDAQ: NASDAQ:SNDX), a clinical stage biopharmaceutical company, has...
Why Bio-Path Stock Is Climbing Today - Bio-Path Hldgs (NASDAQ:BPTH)
Benzinga· 4 days agoBio-Path Holdings, Inc. BPTH shares are trading higher Friday after the company announced interim...
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug
Zacks· 5 days agoSL-172154 is an investigational agonist redirected checkpoint fusion protein, designed to simultaneously inhibit the CD47/SIRPα checkpoint interaction and activate the CD40 costimulatory receptor ...
Kura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of “Moderate Buy” by Analysts
ETF DAILY NEWS· 6 days agoKura Oncology, Inc. (NASDAQ:KURA – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the seven analysts that are covering the stock, Marketbeat Ratings reports ...
Penny Stock Picks: 3 Companies Poised to Graduate to the Big Leagues
InvestorPlace· 1 day agoYou don’t want to overlook these three penny stocks filled to the brim with the potential to make...
Dominari Holdings Inc. (NASDAQ:DOMH) Short Interest Up 191.7% in May
ETF DAILY NEWS· 5 days agoDominari Holdings Inc. (NASDAQ:DOMH – Get Free Report) was the target of a large increase in short interest during the month of May. As of May 31st, there was short interest totalling 3,500 ...
Young cancer warrior still on "Team Victory" for Dallas Mavericks
CBS News· 5 days agoPreston Pipkins has a bedroom that does not require interpretation about who has his support in the...
Educational Development Corporation Announces Executed Fifth Amendment to Credit Agreement
Digital Journal· 23 hours ago...Partners with National Cyber Security to Provide Cyber Protection for Homeowners Biopharma Stocks Quest for Solutions for Acute Myeloid Leukemia (AML) CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment Atlas Lithium Doubles the Size...
MD Anderson Research Highlights: EHA 2024 Special | Newswise
Newswise· 6 days agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research, and prevention. Thes
Cullinan Therapeutics, Inc. (NASDAQ:CGEM) Sees Significant Growth in Short Interest
ETF DAILY NEWS· 15 hours agoCullinan Therapeutics, Inc. (NASDAQ:CGEM – Get Free Report) saw a significant growth in short interest in the month of May. As of May 31st, there was short interest totalling 4,340,000 shares ...